INTAS PHARMACEUTICALS LTD. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for INTAS PHARMACEUTICALS LTD.

Sort by

Viewing results 1‒25 of 2549

The Big Read
The world’s broken market for medicines
...An Indian pharmaceutical manufacturer, Intas, is a major supplier of finished dosage methotrexate to the US through its subsidiary Accord Healthcare....
March 28, 2024
News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
April 22, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Deepmind Technologies Ltd
DeepMind spin-off aims to halve drug discovery times following Big Pharma deals
...Instead, Isomorphic chose to sign deals with just two pharmaceutical companies....
January 10, 2024
Supply chains
US cancer drug shortage forces doctors to ration life-saving treatments
...The cisplatin shortage is linked to quality control problems at a factory in India run by Intas Pharmaceuticals, which provides around half of the US’s entire supply of the chemotherapy drug....
June 4, 2023
Coronavirus treatment
Expired Pfizer Covid antiviral drugs set to cost Europe $2.2bn, data shows
Millions of Paxlovid pills have gone unused as tight controls restrict access
January 1, 2024
LexTeva Pharmaceutical Industries Ltd
Teva Pharma: generics titan attempts to put the stopper in legal problems Premium content
...The leader of the pack was Teva Pharmaceuticals, whose market capitalisation reached $60bn in 2015. Teva now sits in the crosshairs of law enforcement....
August 22, 2023
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
LexFood & Beverage
Pepsi/obesity drugs: snack pack will withstand economies of scales Premium content
Investor worries about the impact of weight loss drugs on food companies are overdone
October 10, 2023
Genomics
Britain’s genetic databank to unveil largest-ever sequencing release
...The latest £200mn project was a collaboration funded by the government, Wellcome Trust, Britain’s biggest biomedical charity, and four pharmaceutical companies....
November 30, 2023
LexBoots UK Ltd
Boots: one step closer to the block Premium content
...The UK pharmaceutical retailer’s transfer of £4.8bn of pension obligations to insurer Legal & General brings its potential sale by owner Walgreens Boots Alliance one step closer....
November 24, 2023
LexDeepmind Technologies Ltd
Google DeepMind: drug developers seek a structural advantage from AI Premium content
Using AI should speed up detection of diseases caused by genetic variants but it does not guarantee success
September 19, 2023
LexPermira Holdings Ltd
Ergomed/Permira: buyout group sees drug trial group as contract thriller Premium content
Private equity group’s bid for researcher comes as the biomedical market is slowing down post-Covid
September 4, 2023
Artificial intelligence
DeepMind uses AI to predict harmful genetic mutations in humans
First example of artificial intelligence helping to accelerate diagnosis of diseases caused by genetic variants
September 19, 2023
Drugs research
New studies find benefits in very early drug treatment of Alzheimer’s
...But until recently, many large pharmaceutical companies were reluctant to invest heavily in finding treatments after decades of failure....
October 25, 2023
The Weekend Essay
Hauser & Wirth: the Swiss gallery that went global
...The virtue of putting private collections on public display is inculcated in Switzerland’s merchant class, the heirs to textile and pharmaceutical fortunes....
March 2, 2024
Disease control and prevention
Japanese drugmaker urges G7 to fix infectious diseases market
Shionogi chief warns companies are deserting the field to focus on more lucrative areas
August 28, 2023
FT Live
Building an AI-First Organisation
How can business leaders use AI to drive value?
Thursday, 25 AprilHôtel Lutetia, Paris, France
Your QuestionsLucy Warwick-Ching
How can I stop my son investing his inheritance in crypto?
...In the second quarter of 2023 the FTSE All-Share pharmaceutical and biotechnology price return index closed 13 per cent higher than the FTSE All Share price return index....
September 20, 2023
Pharmaceuticals sector
Drugmaker warns US data rules threaten access to Alzheimer’s treatment
Japan’s Eisai says it will not finalise Leqembi spending plans until government clarifies financial support
June 17, 2023
Dementia
US regulators approve first drug to slow progression of Alzheimer’s
...It comes after decades during which many big pharmaceutical companies lost hope and cut investment in Alzheimer’s research....
July 6, 2023
Biotech
UK to announce funding boost for life sciences
...Pharmaceutical companies including AstraZeneca and Johnson and Johnson already work with the UK Biobank to access genomic data....
May 24, 2023
Dementia
Two Alzheimer’s drugs offer hope to patients after decades of waiting
...It also generated excitement across the pharmaceutical industry, which is enticed by the prospect of selling medicines to the more than 50mn people worldwide who suffer from the disease....
May 8, 2023
Chinese equities
Pharma and funeral stocks rally as investors ride China’s Covid exit wave
...more than 10 per cent over the past five trading days while Shanghai Fosun Pharmaceutical added 7 per cent....
December 13, 2022
Medical science
High sucralose doses suppress immune system, research on mice shows
Unexpected finding suggests popular sweetener could treat autoimmune conditions such as arthritis and diabetes
March 15, 2023
Starling Bank Ltd
Thirty UK premium stocks that have more conflict-of-interest risk than Starling Bank
...That’d be bad news for Hikma Pharmaceuticals (27.2 per cent). What about board chairs and their deputies?...
May 26, 2023
Healthcare
UK partnerships with life sciences groups threatened by NHS pressures
...Gilead has worked with scientists at Accelerated Clinical Trials Ltd to develop a blood cancer treatment....
May 1, 2023
News in-depthArtificial intelligence
DeepMind spin-off steps up effort to use AI to create new drugs
...Other executives at Isomorphic include Miles Congreve, chief scientific officer, who previously worked at Astex Pharmaceuticals and GSK....
December 3, 2022

Previous pagePage 1 of 102Next page